Company Analysis

West Pharmaceutical Services, Inc. (WST)

NYSE: WST · Surgical & Medical Instruments & Apparatus · Exton, PA · filing with the SEC since 1994
Grade5.7
◀ Past 6.3● Present 6.3▶ Future 4.3

Who owns West Pharmaceutical Services, Inc.

As filed with the SEC
Holders of 5% or more
3
Blackrock, Inc. holds 8.4% of Common Stock, as its SCHEDULE 13G/A filed Apr 24, 2025 says.
Directors and officers
19
report now, of 39 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
8.4%
Vanguard Capital Management
7.48%
Vanguard Portfolio Management
5.69%
Fmr LLC
SCHEDULE 13G · filed Aug 6, 2026 · COMMON STOCK · reported falling below 5%
under 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%, from 13.5% in Oct 31, 2025
under 5%
What WST reports owning in othersstakes of 5% or more, and other ties

41 subsidiaries in 21 countries, from the list filed with the 10-K filed Feb 17, 2026.

Insider tradesForm 4
8sales
0purchases
3sales on a scheduled plan
2people selling
$6.6Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 2, 2025 to Oct 2, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
16171819202122232426
2026 runs to Oct 2, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 39 on the roster
PersonRole as filedSalesSoldOn a planBuysBought
Favorite Annette FSr. VP & Chief HR Officer7$6.3M30$0
Winters ChadVP, Chief Accounting Officer1$300,00000$0
SI Assistanton WST · research, not advice